Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients

被引:17
|
作者
Zhang, Guang-Zhi [1 ,2 ,3 ]
Wu, Zuo-Long [1 ,2 ]
Li, Chun-Ying [4 ]
Ren, En-Hui [1 ,2 ,5 ]
Yuan, Wen-Hua [1 ,2 ]
Deng, Ya-Jun [1 ,2 ]
Xie, Qi-Qi [6 ,7 ,8 ,9 ]
机构
[1] Lanzhou Univ, Clin Med Coll 2, Lanzhou, Peoples R China
[2] Lanzhou Univ, Hosp 2, Dept Orthoped, Lanzhou, Peoples R China
[3] Lintao Cty Tradit Chinese Med Hosp Gansu Prov, Lintao, Peoples R China
[4] Fourth Peoples Hosp Qinghai Prov, Xining, Peoples R China
[5] Xining First Peoples Hosp, Dept Orthopaed, Xining, Peoples R China
[6] Qinghai Univ, Affiliated Hosp, Xining, Peoples R China
[7] Qinghai Univ, Affiliated Canc Hosp, Xining, Peoples R China
[8] Qinghai Univ, Affiliated Hosp, Breast Dis Diag & Treatment Ctr, Xining, Peoples R China
[9] Qinghai Univ, Affiliated Canc Hosp, Xining, Peoples R China
关键词
osteosarcoma; autophagy-related lncRNA; prognostic signature; survival; immune cell infiltration; CELL-PROLIFERATION; IMMUNE-RESPONSE; CANCER; MIGRATION; RNA; CHEMORESISTANCE; TUMORIGENESIS; METASTASIS; EXPRESSION; KNOCKDOWN;
D O I
10.3389/fmolb.2021.615084
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Osteosarcoma is a frequent bone malignancy in children and young adults. Despite the availability of some prognostic biomarkers, most of them fail to accurately predict prognosis in osteosarcoma patients. In this study, we used bioinformatics tools and machine learning algorithms to establish an autophagy-related long non-coding RNA (lncRNA) signature to predict the prognosis of osteosarcoma patients. Methods We obtained expression and clinical data from osteosarcoma patients in the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) and Gene Expression Omnibus (GEO) databases. We acquired an autophagy gene list from the Human Autophagy Database (HADb) and identified autophagy-related lncRNAs by co-expression analyses. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the autophagy-related lncRNAs were conducted. Univariate and multivariate Cox regression analyses were performed to assess the prognostic value of the autophagy-related lncRNA signature and validate the relationship between the signature and osteosarcoma patient survival in an independent cohort. We also investigated the relationship between the signature and immune cell infiltration. Results We initially identified 69 autophagy-related lncRNAs, 13 of which were significant predictors of overall survival in osteosarcoma patients. Kaplan-Meier analyses revealed that the 13 autophagy-related lncRNAs could stratify patients based on their outcomes. Receiver operating characteristic curve analyses confirmed the superior prognostic value of the lncRNA signature compared to clinically used prognostic biomarkers. Importantly, the autophagy-related lncRNA signature predicted patient prognosis independently of clinicopathological characteristics. Furthermore, we found that the expression levels of the autophagy-related lncRNA signature were significantly associated with the infiltration levels of different immune cell subsets, including T cells, NK cells, and dendritic cells. Conclusion The autophagy-related lncRNA signature established here is an independent and robust predictor of osteosarcoma patient survival. Our findings also suggest that the expression of these 13 autophagy-related lncRNAs may promote osteosarcoma progression by regulating immune cell infiltration in the tumor microenvironment.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma
    Ding, Yi
    Li, Tian
    Li, Min
    Tayier, Tuersong
    Zhang, MeiLin
    Chen, Long
    Feng, ShuMei
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [2] Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients
    Daixing Hu
    Li Jiang
    Shengjun Luo
    Xin Zhao
    Hao Hu
    Guozhi Zhao
    Wei Tang
    Journal of Translational Medicine, 18
  • [3] Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients
    Hu, Daixing
    Jiang, Li
    Luo, Shengjun
    Zhao, Xin
    Hu, Hao
    Zhao, Guozhi
    Tang, Wei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [4] Development of an autophagy-related gene expression signature for long term prognosis prediction in neuroblastoma patients
    Kang, W.
    Hu, J.
    Song, F.
    Zhao, Q.
    ANNALS OF ONCOLOGY, 2021, 32 : S1241 - S1241
  • [5] Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes
    Qi, Wei
    Yan, Qian
    Lv, Ming
    Song, Delei
    Wang, Xianbin
    Tian, Kangsong
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [6] Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients
    Huo, Xingxing
    Qi, Jian
    Huang, Kaiquan
    Bu, Su
    Yao, Wei
    Chen, Ying
    Nie, Jinfu
    BMC CANCER, 2020, 20 (01)
  • [7] Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients
    Xingxing Huo
    Jian Qi
    Kaiquan Huang
    Su Bu
    Wei Yao
    Ying Chen
    Jinfu Nie
    BMC Cancer, 20
  • [8] A Six Autophagy-Related LncRNA Signature Associated with Clinical Prognosis in Prostate Cancer
    Lu, Yangbai
    Yuan, Runqiang
    Huang, Hongxing
    Chen, Zheng
    Qin, Xiaoping
    Chen, Jianfan
    Jiang, Junbin
    Zhuo, Yumin
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2021, 25 (09) : 573 - 581
  • [9] Development of an Autophagy-Related Gene Expression Signature for Long Term Prognosis Prediction in Neuroblastoma
    Hu, J.
    Song, F.
    Kang, W.
    Zhao, Q.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S65 - S66
  • [10] A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma
    Gong, Zetian
    Li, Qifan
    Li, Jun
    Xie, Jiaheng
    Wang, Wei
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (01) : 14 - 28